Balyasny Asset Management
AMAM

Balyasny Asset Management’s Ambrx Biopharma, Inc. Common Stock AMAM Stock Holding History

Balyasny Asset Management’s Portfolio AMAM Stock Details AMAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,154,700
Closed -$30.7M – 2539
2023
Q4 		$30.7M Buy
+2,154,700
New +$30.7M 0.06% 333